April 29 (Reuters) - Italy's Chiesi has agreed to buy KalVista Pharmaceuticals ( KALV ) for about $1.9 billion, the company said on Wednesday, as it looks to grow its rare disease drug portfolio. ...

April 29 (Reuters) - AbbVie ( ABBV ) on Wednesday reported better-than-expected quarterly revenue and profit, fueled by demand for newer immunology drugs Skyrizi and Rinvoq, as the drugmaker continues to navigate its transition away from its once-blockbuster drug, Humira. The company has been leaning heavily on Skyrizi and Rinvoq to fill the void left by Humira, which lost U.S....

April 29 (Reuters) - AbbVie ( ABBV ) on Wednesday reported better-than-expected quarterly revenue and profit, fueled by demand for newer immunology drugs Skyrizi and Rinvoq, as the drugmaker continues to navigate its transition away from its once-blockbuster drug, Humira. The company has been leaning heavily on Skyrizi and Rinvoq to fill the void left by Humira, which lost U.S....

07:50 AM EDT, 04/29/2026 (MT Newswires) -- Canadian National Railway ( CNI ) reported Q1 adjusted earnings Wednesday of 1.80 Canadian dollars ($0.79) per diluted share, compared with CA$1.85 a year earlier. Analysts surveyed by FactSet expected CA$1.80. Revenue for the quarter ended March 31 was CA$4.38 billion, compared with CA$4.40 billion a year earlier. Analysts surveyed by FactSet expected...